Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Leptin for Vascular Function in Healthy Adults
NCT00121433Phase 4Completed
- Sponsor
- University of Michigan
- Start
- Sep 2004
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Phase 4, randomised, double-blind trial of metreleptin in obesity (2 arms), sponsored by University of Michigan. Primary endpoint: flow-mediated dilatation of the brachial artery at 6 hours. Started Sep 2004; status: completed.
02
Drugs
metreleptin
03
Conditions
obesity
Beyond the preview
Go deeper on NCT00121433.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00121433.